Tumor Mutation Score Is More Powerful Than Tumor Mutation Burden in Predicting Response to Immunotherapy in Non-Small Cell Lung Cancer

被引：0
|
作者：
Li, Y. [1 ]
Chen, Z. [2 ]
Wu, L. [1 ]
Tao, W. [1 ]
机构：
[1] Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan, Hubei, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Tumor Mutation Score; Tumor Mutation Burden; PD-L1;
D O I：
10.1016/j.jtho.2019.08.1545
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.04-40
引用
收藏
页码：S724 / S724
页数：1
相关论文
共 50 条
  • [21] Clinical and genomic features of high tumor mutation burden in patients with non-small cell lung cancer.
    Qiu, Yuan
    Yang, Haihong
    Chen, Hanzhang
    Deng, Qiuhua
    Liu, Liping
    Xiao, Dakai
    Shao, Di
    Li, Weiwei
    Jiang, Wenxi
    Zhu, Changbin
    Lin, Yongping
    He, Jianxing
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] PD-L1 versus tumor mutation burden: Which is the better immunotherapy biomarker in advanced non-small cell lung cancer?
    Dong, Aoran
    Zhao, Yiming
    Li, Zhihua
    Hu, Hai
    JOURNAL OF GENE MEDICINE, 2021, 23 (02):
  • [23] Tumor Mutation Burden in lung cancer
    Carbone, David P.
    ANNALS OF ONCOLOGY, 2019, 30 : 27 - 27
  • [24] Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer
    Wu, Jiani
    Wang, Yuanyuan
    Huang, Zhenhua
    Wu, Jingjing
    Sun, Huiying
    Zhou, Rui
    Qiu, Wenjun
    Ye, Zilan
    Fang, Yiran
    Huang, Xiatong
    Wu, Jianhua
    Bin, Jianping
    Liao, Yulin
    Shi, Min
    Wang, Jiguang
    Liao, Wangjun
    Zeng, Dongqiang
    ISCIENCE, 2024, 27 (12)
  • [25] Relationship between the efficacy of immunotherapy and characteristics of specific tumor mutation genes in non-small cell lung cancer patients
    Song, Peng
    Yang, Dongliang
    Wang, Hanping
    Cui, Xiaoxia
    Si, Xiaoyan
    Zhang, Xiaotong
    Zhang, Li
    THORACIC CANCER, 2020, 11 (06) : 1647 - 1654
  • [26] The Prognostic Effect of Tumor Mutation Burden and Smoking History in Resected EGFR Mutant Non-Small Cell Lung Cancer
    Sorotsky, H.
    Cabanero, M.
    Moskovitz, M.
    Weiss, J.
    Pintilie, M.
    Leighl, N.
    Bradbury, P.
    Liu, G.
    Kia, A.
    Pugh, T.
    Torti, D.
    Torchia, J.
    Tsao, M.
    Shepherd, F.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S921 - S921
  • [27] Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non-Small Cell Lung Cancer: Brief Report
    Owada-Ozaki, Yuki
    Muto, Satoshi
    Takagi, Hironori
    Inoue, Takuya
    Watanabe, Yuzuru
    Fukuhara, Mitsuro
    Yamaura, Takumi
    Okabe, Naoyuki
    Matsumura, Yuki
    Hasegawa, Takeo
    Ohsugi, Jun
    Hoshino, Mika
    Shio, Yutaka
    Nanamiya, Hideaki
    Imai, Jun-ichi
    Isogai, Takao
    Watanabe, Shinya
    Suzuki, Hiroyuki
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (08) : 1217 - 1221
  • [28] Uncommon EGFR mutations are associated with higher tumor mutation burden (TMB) in non-small cell lung cancer patients
    Shen, Xudong
    Zhang, Hushan
    Huang, Depei
    CANCER RESEARCH, 2020, 80 (16)
  • [29] Utilization of Genomic Mutation Signature to Predict the Immunotherapy Response in Non-small Cell Lung Cancer
    Wu, X.
    Song, P.
    Ying, J.
    Gao, S.
    Li, W.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S58 - S59
  • [30] EGFR mutation analysis in circulating tumor cells and matched tumor of patients with non-small cell lung cancer
    Toh, Chee Keong
    Sng, Natasha
    Loh, Marie
    Wong, Alvin
    Yeo, Wee-Lee
    Chin, Tan Min
    Ng, Min-En
    Lim, Wan-Teck
    Soong, Richie
    Soo, Ross A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S928 - S928
12345